# Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

> **NCT01824368** · PHASE1,PHASE2 · COMPLETED · sponsor: **Red de Terapia Celular** · enrollment: 10 (actual)

## Conditions studied

- Liver Transplantation
- Immunosuppression

## Interventions

- **PROCEDURE:** Extracorporeal Photopheresis Procedure (FEC)

## Key facts

- **NCT ID:** NCT01824368
- **Lead sponsor:** Red de Terapia Celular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824368, "Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01824368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*